Journal of Experimental Medicine

The Journal of Experimental Medicine is a peer-reviewed academic journal published by the Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesisas, cancer, stem cells and vascular biology. The JEM is second highest (based on impact factor) among the journals that publish basic research articles from all fields of biomedicine. Among all biomedical journals (specialized or nonspecialized) JEM stands among the top 10. The JEM was founded in 1896 at the Johns Hopkins School of Medicine by William H. Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute (since re-named the Rockefeller University). From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the

Publisher
Rockefeller University Press
Country
United States
History
1896–present
Website
http://www.jem.org/
Impact factor
14.776 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Immunology

The making of memory B cells and long-term immune responses

The current COVID-19 climate has made vaccines, antibodies and immune responses topics of everyday conversation. Now, it isn't just immunologists who want to know how our bodies respond to re-infections months, years, or ...

Medical research

A small T cell switch with a big impact

T cells play a key role in the human immune system. They are capable of distinguishing diseased or foreign tissue from the body's own, healthy tissue with great accuracy; they are capable of triggering the actions necessary ...

Medical research

A protein for the mass production of antibodies

Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic. These minute proteins, also called immunoglobulins, are ...

Genetics

DNA webs may drive lung pathology in severe COVID-19

Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental ...

Diseases, Conditions, Syndromes

Hepatitis B: Natural controllers shed light on immunity mechanisms

Infections in humans caused by the hepatitis B virus (HBV) represent a major public health problem. Despite the availability of effective protective vaccines, more than 250 million individuals worldwide are chronically infected ...

page 1 from 36